Welcome to our dedicated page for ASNB news (Ticker: ASNB), a resource for investors and traders seeking the latest updates and insights on ASNB stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ASNB's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ASNB's position in the market.
EKIMAS Corporation (OTC PINK: ASNB) announced the exercise of 115,000 warrants at $1.00 per share, totaling $115,000 in capital, from its largest shareholder as part of a 6,000,000-warrant grant made in April 2022. The CEO, Henrik Rouf, highlighted the importance of this funding for executing both short- and long-term strategic plans, particularly in expanding EKIMAS’ presence in the U.S. market. The company’s subsidiary, Nordicus Partners A/S, specializes in assisting Nordic companies to establish themselves in the U.S., leveraging over 90 years of management experience in corporate finance.
Nordicus Partners A/S, a financial consulting firm, has completed a reverse acquisition with EKIMAS Corporation (OTC PINK: ASNB), giving Nordicus 30.1% ownership of EKIMAS through the issuance of 2,500,000 shares. Following the acquisition, EKIMAS will become a wholly-owned subsidiary of Nordicus, which will change its name to Nordicus Partners Corporation and update its ticker symbol. Key board members from Nordicus have been appointed to EKIMAS’s board, including Henrik Rouf as CEO. This merger aims to enhance Nordicus’s expertise in helping Nordic companies penetrate the U.S. market, significantly impacting growth potential.
EKIMAS Corporation (OTC Pink: ASNB) announced a special cash distribution of $0.25 per share approved by its Board of Directors on September 12, 2022. This distribution is set for September 22, 2022, payable to shareholders of record as of March 15, 2022. The company is actively exploring merger opportunities to enhance value for shareholders but has not yet entered into any binding agreements. Investors are cautioned that forward-looking statements regarding potential value additions may involve significant risks and uncertainties.
EKIMAS Corporation (OTC Pink: ASNB) has approved a special cash distribution of $0.25 per share during its Board meeting on September 8, 2022. This distribution is set to be paid on September 19, 2022 to shareholders of record as of March 11, 2022.
The company is exploring potential mergers or acquisitions to enhance shareholder value, yet there are no binding agreements in place at this time. Forward-looking statements are included in this release, emphasizing potential risks and uncertainties associated with future expectations.
FAQ
What is the market cap of ASNB (ASNB)?
